• WHO and all partner organizations should continue to actively disseminate the Guidelines, and should encourage all governments and organizations involved in drug donations to formulate their own guidelines.

• WHO should involve as many partners as possible in the next version of the Guidelines. International organizations which have expressed an interest should be invited to become co-sponsors of the second version. Examples of such organizations are Caritas Internationalis, the International Pharmaceutical Federation, Pharmaciens Sans Frontières, UNAIDS, the United Nations Development Programme, the United Nations Population Fund, and the World Bank.

• WHO should expand the section in the Guidelines on the management of drug donations, stressing the need for rapid clearance of drug donations and reconfirming the justification of certain exceptions to the minimum shelf-life provision.